Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Parkinson's disease | R-HSA-1643685 | 0 | thioguanosine | 4114 | drug-path |
| Cardiac muscle contraction | R-HSA-397014 | map04260 | thioguanosine | 4114 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | thioguanosine | 4114 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | thioguanosine | 4114 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | thioguanosine | 4114 | drug-path |
| Proteasome | R-HSA-68819 | map03050 | thioguanosine | 4114 | drug-path |
| Long-term depression | R-HSA-9620244 | map04730 | thioguanosine | 4114 | drug-path |
| Complement and coagulation cascades | R-HSA-114591 | map04610 | thioguanosine | 4114 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | procainamide | 4913 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | procainamide | 4913 | drug-path |
| Shigellosis | 0 | map05131 | procainamide | 4913 | drug-path |
| Leukocyte transendothelial migration | R-HSA-8950732 | map04670 | procainamide | 4913 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | procainamide | 4913 | drug-path |
| Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | procainamide | 4913 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | procainamide | 4913 | drug-path |
| Focal adhesion | R-HSA-354113 | map04510 | procainamide | 4913 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | procainamide | 4913 | drug-path |
| Pancreatic cancer | R-HSA-9700206 | map05212 | procainamide | 4913 | drug-path |
| Prostate cancer | R-HSA-2990872 | map05215 | procainamide | 4913 | drug-path |
| Melanoma | Q9UHD0-PRO_0000015379 | map05218 | procainamide | 4913 | drug-path |